Seqens is a Manufacturer/Innovator, CMO/CDMO, Drug delivery device Supplier/Manufacturer company operating in the pharmaceutical industry.
SEQENS is a worldwide leader in the development and production of pharmaceutical solutions leveraging a strong industrial network, 10 R&D centers and 3,500 employees in 9 countries. As an integrated player across the value chain – from raw materials to active ingredients and from research and development to industrialization – SEQENS offers a broad portfolio of APIs, pharmaceutical intermediates and excipients.
Company type
Manufacturer/Innovator, CMO/CDMO, Drug delivery device Supplier/Manufacturer
Products and services
Custom Manufacturing, Intermediates, Fine and Specialty Chemicals, APIs (Active Pharmaceutical Ingredients), Contract Services – Analytical & Lab Services
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Seqens on LinkedIn
Address
Seqens, 21 chemin de la sauverdarde, Ecully, France, 69130
